Chemotherapy Clinical Trials

308 recruitingLast updated: June 17, 2026

There are 308 actively recruiting chemotherapy clinical trials across 43 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1. Top locations include Guangzhou, Guangdong, China, Beijing, China, Shanghai, China. Updated daily from ClinicalTrials.gov.


Chemotherapy Trials at a Glance

308 actively recruiting trials for chemotherapy are listed on ClinicalTrialsFinder across 6 cities in 43 countries. The largest study group is Not Applicable with 96 trials, with the heaviest enrollment activity in Guangzhou, Beijing, and Shanghai. Lead sponsors running chemotherapy studies include Sun Yat-sen University, M.D. Anderson Cancer Center, and Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

Browse chemotherapy trials by phase

Treatments under study

About Chemotherapy Clinical Trials

Looking for clinical trials for Chemotherapy? There are currently 56 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chemotherapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chemotherapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 308 trials

Recruiting
Phase 1Phase 2

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals123 enrolled19 locationsNCT07226986
Recruiting
Not Applicable

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Chemotherapy Induced Peripheral NeuropathyCancerChildhood Cancer
Yale University20 enrolled2 locationsNCT07019259
Recruiting
Not Applicable

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

Breast CancerBreast NeoplasmSymptom Management+4 more
Dena h. Al-Tameemi130 enrolled1 locationNCT07273812
Recruiting
Phase 1Phase 2

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

Myeloid MalignanciesLymphodepleting Chemotherapy
M.D. Anderson Cancer Center44 enrolled1 locationNCT06383572
Recruiting
Phase 2

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University180 enrolled1 locationNCT06510010
Recruiting
Not Applicable

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

Chemotherapy-induced Peripheral Neuropathy (CIPN)
Luminate Medical, Inc.142 enrolled18 locationsNCT07142304
Recruiting
Not Applicable

Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis

Colorectal, CancerAdjuvant Chemotherapy
Sixth Affiliated Hospital, Sun Yat-sen University650 enrolled1 locationNCT03748485
Recruiting

FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases

Antineoplastic Combined Chemotherapy ProtocolsRectal CancerSynchronous Liver Metastases+1 more
Assistance Publique - Hôpitaux de Paris550 enrolled1 locationNCT07467434
Recruiting
Phase 3

Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy

OncologyCachexia-Anorexia SyndromeOncology Patients Receiving Chemotherapy
Blokhin's Russian Cancer Research Center100 enrolled1 locationNCT07633236
Recruiting
Phase 3

Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)
University Health Network, Toronto240 enrolled1 locationNCT07481149
Recruiting
Not Applicable

Inactivated Bacteroides Fragilis for Prevention of Chemotherapy-Induced Diarrhea

Chemotherapy-induced Diarrhea
Shenzhen Hospital of Southern Medical University200 enrolled1 locationNCT07309315
Recruiting
Not Applicable

Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy Induced Peripheral NeuropathyCIPN - Chemotherapy-Induced Peripheral Neuropathy
Case Comprehensive Cancer Center90 enrolled1 locationNCT07219472
Recruiting
Not Applicable

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

Chemotherapy Induced Peripheral NeuropathyGynecologic Cancer
Duke University190 enrolled4 locationsNCT06139458
Recruiting
Phase 2

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Nausea and Vomiting Chemotherapy-InducedNausea Post Chemotherapy
Helsinn Healthcare SA95 enrolled20 locationsNCT06904235
Recruiting
Phase 2

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Colorectal, CancerMinimal Residual DiseasectDNA+3 more
M.D. Anderson Cancer Center20 enrolled1 locationNCT07136077
Recruiting
Phase 2

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Chemotherapy Induced Neuropathic PainChemotherapy Induced Pain NeuropathyChemotherapy Induced Pain
Dogwood Therapeutics Inc.240 enrolled25 locationsNCT06848348
Recruiting
Phase 2

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more
AstraZeneca257 enrolled95 locationsNCT06535607
Recruiting
Not Applicable

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

ChemotherapyCancerFrail
Wake Forest University Health Sciences32 enrolled2 locationsNCT07175376
Recruiting
Phase 2

Personalized NK Cell Therapy in CBT

Acute Lymphoblastic LeukemiaMyelodysplastic SyndromeChronic Myelomonocytic Leukemia+23 more
M.D. Anderson Cancer Center100 enrolled1 locationNCT02727803
Recruiting
Not Applicable

Taste Alterations Study

Chemotherapy Side EffectsTaste, Altered
Wake Forest University Health Sciences400 enrolled1 locationNCT06669416